Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Katherine Anne Janeway, M.D.

Concepts (408)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Osteosarcoma4120249117.490 Why?
Bone Neoplasms51202525655.680 Why?
Gastrointestinal Stromal Tumors1620216172.700 Why?
Neuroectodermal Tumors, Primitive, Peripheral42023432.000 Why?
Gastrointestinal Neoplasms820219591.220 Why?
Neoplasms302024223891.210 Why?
High-Throughput Nucleotide Sequencing9202436661.120 Why?
Succinate Dehydrogenase620161481.110 Why?
Child1062025808941.000 Why?
Sarcoma10202418060.940 Why?
Neoplasm Recurrence, Local22202494330.910 Why?
Protein-Tyrosine Kinases4202224330.890 Why?
Molecular Targeted Therapy13202428300.890 Why?
Clinical Trials, Phase II as Topic320166400.880 Why?
Receptor, Platelet-Derived Growth Factor alpha620193680.840 Why?
Fibromatosis, Aggressive320201250.830 Why?
Oncogene Proteins, Fusion8202316140.750 Why?
Neoplasms, Muscle Tissue12021670.750 Why?
Antineoplastic Combined Chemotherapy Protocols202024118540.710 Why?
Medical Oncology9202323480.710 Why?
Proto-Oncogene Proteins c-kit720197250.710 Why?
Ketones220181820.690 Why?
Furans220182010.690 Why?
Antineoplastic Agents122020136960.680 Why?
Adolescent702024891820.650 Why?
Paraganglioma520221430.640 Why?
Germ-Line Mutation11202518850.610 Why?
Receptor, IGF Type 1420193840.600 Why?
Piperazines5202425520.580 Why?
Clinical Trials as Topic10202480510.580 Why?
Central Nervous System Neoplasms220239300.570 Why?
Genomics16202459160.560 Why?
Doxorubicin7202322290.520 Why?
Child, Preschool432025426540.520 Why?
Information Dissemination1202411370.510 Why?
Proto-Oncogene Proteins4202245260.510 Why?
Soft Tissue Neoplasms5202311660.500 Why?
Pediatrics5202036240.470 Why?
Ifosfamide520242340.460 Why?
Mutation222024302300.450 Why?
Gene Fusion320223560.450 Why?
Marketing of Health Services120151510.450 Why?
Adrenal Gland Neoplasms420227360.440 Why?
Protein Kinase Inhibitors10202357070.430 Why?
Cyclin-Dependent Kinase 4420245660.420 Why?
Humans14220257682980.420 Why?
Antibiotics, Antineoplastic120166770.420 Why?
Pheochromocytoma320223280.390 Why?
TOR Serine-Threonine Kinases3202420660.390 Why?
Etoposide520246390.390 Why?
Sarcoma, Clear Cell22023720.390 Why?
Immunoconjugates120199690.390 Why?
Ambulatory Care Facilities120179400.360 Why?
Young Adult382024600480.350 Why?
Cell Respiration120102010.350 Why?
Neoadjuvant Therapy3201929090.340 Why?
Cyclin-Dependent Kinase 6320243540.340 Why?
Gene Amplification3202310900.340 Why?
Infant252024365120.340 Why?
DNA Mutational Analysis3201641200.330 Why?
Vincristine5202410400.330 Why?
Pyrimidines3202430480.330 Why?
Lung Neoplasms42023135760.310 Why?
Genetic Predisposition to Disease82025180470.300 Why?
Prognosis192023300200.300 Why?
Tissue Banks320201840.290 Why?
Amyloid Precursor Protein Secretases220226140.280 Why?
Female6420253970500.280 Why?
Fibrosarcoma220203130.280 Why?
Feasibility Studies2202153110.280 Why?
Phosphatidylinositol 3-Kinases2202428840.270 Why?
Patient Selection2201742650.270 Why?
Proteins1202160060.270 Why?
Electron Transport Complex II32019530.270 Why?
National Cancer Institute (U.S.)620243000.270 Why?
Male6020253648700.270 Why?
Ovarian Neoplasms1202349080.270 Why?
Pyrroles2202411260.250 Why?
Antibodies, Monoclonal3202392610.230 Why?
Genomic Structural Variation12025800.230 Why?
Adult4220252236220.220 Why?
Disease-Free Survival5202368560.220 Why?
Genetic Testing3201735870.220 Why?
Rare Diseases220216300.220 Why?
Busulfan120242590.220 Why?
Myofibromatosis12023270.210 Why?
Receptor, Platelet-Derived Growth Factor beta220231830.210 Why?
Melphalan120244210.210 Why?
Internet1201531070.200 Why?
Genome, Human2201744500.200 Why?
BRCA1 Protein3202411580.200 Why?
Hematologic Neoplasms1201419060.200 Why?
Plasma Cell Granuloma, Pulmonary12021120.200 Why?
Cyclophosphamide3202422260.200 Why?
Receptor Protein-Tyrosine Kinases4202216280.200 Why?
BRCA2 Protein220248020.190 Why?
Glomus Tumor12022620.190 Why?
Phthalazines120243970.190 Why?
Transplantation, Autologous2202421270.190 Why?
Rhabdoid Tumor120232110.190 Why?
Topotecan120211310.190 Why?
Granuloma, Plasma Cell12022800.190 Why?
Phenylurea Compounds120245290.190 Why?
Neoplasms, Neuroepithelial12021430.190 Why?
Loss of Heterozygosity120236630.180 Why?
Indenes12021590.180 Why?
Indoles1200918250.180 Why?
Polycythemia120211240.180 Why?
Pelvic Neoplasms120222500.180 Why?
Tandem Repeat Sequences120211830.180 Why?
Tetrahydronaphthalenes12020860.170 Why?
Infant, Newborn92024264100.170 Why?
Biomedical Research3202134640.170 Why?
Sequence Analysis, RNA4202120380.170 Why?
Brain Neoplasms4202391970.170 Why?
DEAD-box RNA Helicases220203840.170 Why?
Treatment Outcome132024653650.170 Why?
Neoplasms, Unknown Primary120201010.170 Why?
Myofibroma12019450.160 Why?
Receptor, erbB-22202425880.160 Why?
Quinolines120247680.160 Why?
Chromosomes, Human, Pair 14220172860.160 Why?
Nomograms120202360.160 Why?
Benzamides3202313800.160 Why?
Valine120204100.160 Why?
Carcinoma, Medullary120191160.150 Why?
Kidney Neoplasms3202143010.150 Why?
Proto-Oncogene Proteins c-ret120202280.150 Why?
Gene Expression Regulation, Neoplastic6202086280.150 Why?
Drug Resistance, Neoplasm4201953350.150 Why?
Ribonuclease III120202700.150 Why?
Dystrophin120192840.150 Why?
Nephroma, Mesoblastic12017240.150 Why?
Epigenomics320199590.150 Why?
Parotid Neoplasms120191580.150 Why?
Neoplasm Metastasis6201949210.150 Why?
Resource Allocation120203540.150 Why?
Legislation, Drug120202160.150 Why?
DNA Repair2202420500.150 Why?
Tumor Suppressor Protein p533201929500.140 Why?
Glioma2202235260.140 Why?
Retrospective Studies172024817680.140 Why?
Vascular Endothelial Growth Factor Receptor-2120195500.140 Why?
Microtubule-Associated Proteins2202210780.140 Why?
Benzimidazoles120228640.140 Why?
Informed Consent1202310100.130 Why?
Neuroblastoma1202512650.130 Why?
Li-Fraumeni Syndrome120171170.130 Why?
von Hippel-Lindau Disease120171540.130 Why?
Proto-Oncogene Proteins B-raf2202420580.130 Why?
Karyopherins120161340.130 Why?
Carcinoma, Neuroendocrine120193420.130 Why?
Specimen Handling120207070.130 Why?
Basic Helix-Loop-Helix Transcription Factors1202111410.120 Why?
Survival Rate52019128700.120 Why?
SEER Program1202014740.120 Why?
Genomic Imprinting120173240.120 Why?
Pelvic Bones120172740.120 Why?
Disease Models, Animal22014183580.120 Why?
Histone-Lysine N-Methyltransferase120196970.120 Why?
United States Food and Drug Administration3202216720.120 Why?
RNA, Neoplasm120177490.120 Why?
Pyridines2202428890.120 Why?
Immunotherapy, Adoptive1202415080.110 Why?
Pyrazines1201912060.110 Why?
Hematopoietic Stem Cell Transplantation2202457110.110 Why?
Imidazoles1201911680.110 Why?
United States152024731440.110 Why?
Endpoint Determination120165940.110 Why?
Cell Line, Tumor72022171320.110 Why?
Databases, Factual3202380720.110 Why?
Follow-Up Studies82020394050.100 Why?
Repressor Proteins2202129860.100 Why?
Age Factors52024184720.100 Why?
Prospective Studies102024549210.100 Why?
Leukemia1202115260.100 Why?
Poverty1202427210.100 Why?
Cisplatin3201916610.100 Why?
Drug Evaluation, Preclinical2201613390.100 Why?
Proteasome Endopeptidase Complex1201913200.100 Why?
Serine Endopeptidases1201710260.100 Why?
Age of Onset1201933450.100 Why?
Patient Participation1202114480.100 Why?
Glucocorticoids1202121680.100 Why?
DNA Copy Number Variations2201920460.100 Why?
Methotrexate3201917220.100 Why?
Extremities120178700.100 Why?
Gastrectomy120166960.100 Why?
Combined Modality Therapy4202285620.100 Why?
Receptors, Cytoplasmic and Nuclear120168610.100 Why?
Cerebellar Neoplasms120165900.090 Why?
Cell Survival1202157920.090 Why?
Genetic Heterogeneity120147370.090 Why?
Gene Dosage2201712210.090 Why?
Medulloblastoma120166820.090 Why?
Polyethylene Glycols1201611950.090 Why?
RNA Processing, Post-Transcriptional120133930.090 Why?
Membrane Proteins3201778850.090 Why?
Syndrome2202132750.090 Why?
Cell Cycle Proteins2202234570.090 Why?
Antidotes120101380.080 Why?
MicroRNAs2201737940.080 Why?
In Situ Hybridization, Fluorescence3202125240.080 Why?
Biopsy4202468080.080 Why?
DNA Damage3202424590.080 Why?
Germ Cells220236430.080 Why?
Nasopharyngeal Neoplasms120112900.080 Why?
Mitogen-Activated Protein Kinases2202412460.080 Why?
Heart Neoplasms120123740.080 Why?
Treatment Failure2201726640.080 Why?
Mediastinal Neoplasms120114030.070 Why?
Ecosystem220234940.070 Why?
Polymorphism, Single Nucleotide42017160270.070 Why?
Protein Subunits120109430.070 Why?
Dose-Response Relationship, Drug12019107760.070 Why?
Pedigree1201445450.070 Why?
Translocation, Genetic2202313950.070 Why?
Survivors2202323820.070 Why?
Disease Progression52021136460.070 Why?
Diagnosis, Differential12021130190.070 Why?
Head and Neck Neoplasms1202029230.070 Why?
Oncogenes2202212340.070 Why?
Thyroid Neoplasms1201923600.070 Why?
Neurotoxicity Syndromes120103020.060 Why?
Mice, Nude3201936300.060 Why?
Immunohistochemistry32019111170.060 Why?
Cyclin D12024720.060 Why?
Chromosome Aberrations2202517800.060 Why?
Immunotherapy2202147400.060 Why?
Melanoma1202357050.060 Why?
Risk Assessment32020243160.060 Why?
Neoplastic Cells, Circulating120119570.060 Why?
Forecasting1201329480.060 Why?
Neoplasm Transplantation2201920170.060 Why?
Pancreatic Neoplasms1202154430.060 Why?
Computer Simulation1201762770.050 Why?
Clinical Protocols2202214450.050 Why?
Gene Expression Profiling5201795080.050 Why?
Infertility120106550.050 Why?
Blotting, Western1201050330.050 Why?
Adenocarcinoma1202064040.050 Why?
Nuclear Proteins2202358020.050 Why?
Cyclic AMP Response Element Modulator12023880.050 Why?
Vidarabine120243370.050 Why?
Hearing Loss120107860.050 Why?
Attitude of Health Personnel1201639210.050 Why?
Normetanephrine12021250.050 Why?
Lymphocyte Depletion120246050.050 Why?
Neoplasms, Second Primary1201010600.050 Why?
Dogs2201938460.050 Why?
Inflammation12021108630.050 Why?
Enzyme Activation1200735850.050 Why?
3-Iodobenzylguanidine120221150.050 Why?
Middle Aged1420242234630.050 Why?
Research Design2201762090.050 Why?
Chromogranins120211600.050 Why?
Microphthalmia-Associated Transcription Factor120232560.050 Why?
Trismus12020330.050 Why?
Sacrum120222750.040 Why?
DNA Methylation4201744190.040 Why?
Survival Analysis32018101170.040 Why?
Desmoplastic Small Round Cell Tumor12020330.040 Why?
Signal Transduction52021236290.040 Why?
Oncogene Proteins220177180.040 Why?
Aminopyridines120245800.040 Why?
RNA-Binding Protein EWS120212110.040 Why?
Poly(ADP-ribose) Polymerases120224270.040 Why?
Oncogene Fusion12020830.040 Why?
Cell Differentiation22023116590.040 Why?
RNA2202227260.040 Why?
Polymerase Chain Reaction1200960840.040 Why?
Codon120215990.040 Why?
Phosphorylation1201083260.040 Why?
Mice62022820040.040 Why?
Cell Cycle2201929340.040 Why?
Mitogen-Activated Protein Kinase Kinases120226360.040 Why?
Receptor, Notch1120225200.040 Why?
Animals920221693220.040 Why?
Kidney Diseases1201021030.040 Why?
Adrenal Glands120215570.040 Why?
RNA Interference2201928360.040 Why?
Xenograft Model Antitumor Assays2201836160.040 Why?
Cell Proliferation12014104640.040 Why?
Granulocyte-Macrophage Colony-Stimulating Factor120228920.040 Why?
Pathology, Molecular120213290.040 Why?
Workers' Compensation119991500.040 Why?
Calcitonin120193290.040 Why?
DNA Helicases120238530.040 Why?
Carbazoles120192210.040 Why?
Endothelial Cells1201135870.040 Why?
Radionuclide Imaging1202219980.040 Why?
Stem Cells1201135370.040 Why?
Proportional Hazards Models32017125570.040 Why?
GTP-Binding Proteins120229470.040 Why?
Cohort Studies52021417910.040 Why?
Drug Labeling120202500.040 Why?
Insulin-Like Growth Factor Binding Protein 212017680.040 Why?
American Cancer Society12017690.040 Why?
Utah120171300.040 Why?
Breast Neoplasms22022211630.030 Why?
MAP Kinase Signaling System1202414920.030 Why?
Heart Diseases1201028190.030 Why?
Receptors, Platelet-Derived Growth Factor120171780.030 Why?
Sequence Analysis, DNA2201847740.030 Why?
Proto-Oncogene Proteins c-ets120173140.030 Why?
Receptors, Fibroblast Growth Factor120171960.030 Why?
Risk Factors52025749540.030 Why?
Necrosis1202016190.030 Why?
Minor Histocompatibility Antigens120173030.030 Why?
Comparative Genomic Hybridization120174740.030 Why?
MAP Kinase Kinase Kinases120172520.030 Why?
Safety1202011590.030 Why?
Aged820241715440.030 Why?
Carpal Tunnel Syndrome119993040.030 Why?
Exons1202123920.030 Why?
Educational Status1202325180.030 Why?
T-Lymphocytes22024102660.030 Why?
Consensus1202432120.030 Why?
Practice Guidelines as Topic1201274530.030 Why?
Hydrazines120162230.030 Why?
Molecular Diagnostic Techniques120196200.030 Why?
Drug Synergism1201817600.030 Why?
Microarray Analysis120177530.030 Why?
Radiotherapy, Adjuvant1201917940.030 Why?
Proto-Oncogene Proteins p21(ras)1202217650.030 Why?
Ubiquitin Thiolesterase120174620.030 Why?
Cytoskeletal Proteins1201913370.030 Why?
Ubiquitin120198430.030 Why?
Data Collection1202333240.030 Why?
Drug Screening Assays, Antitumor120167200.030 Why?
Computational Biology2201735410.030 Why?
Fluorodeoxyglucose F181202220560.030 Why?
National Institutes of Health (U.S.)120167940.030 Why?
Small Molecule Libraries120187430.030 Why?
Motivation1202320290.030 Why?
Chromatin1202529670.030 Why?
Models, Biological2202194940.030 Why?
Drug Approval120208180.030 Why?
Aged, 80 and over42021596830.030 Why?
Early Detection of Cancer2201732360.030 Why?
Europe1201934390.030 Why?
Ubiquitin-Protein Ligases1202219020.030 Why?
Pneumonectomy1201911580.030 Why?
Neoplasm Proteins2201736090.020 Why?
Radiopharmaceuticals1202227340.020 Why?
Self Efficacy120166430.020 Why?
Tumor Suppressor Proteins1202228110.020 Why?
DNA, Neoplasm1201717480.020 Why?
Base Sequence12022124210.020 Why?
Regression Analysis1202063500.020 Why?
Immunoenzyme Techniques1201417050.020 Why?
Piperidines1201916600.020 Why?
Triazoles120169040.020 Why?
Sex Factors12025106560.020 Why?
Cardiovascular Surgical Procedures120121930.020 Why?
Quality of Life22022134990.020 Why?
Lymphatic Metastasis1201829240.020 Why?
Genes, Tumor Suppressor1201510640.020 Why?
Reproducibility of Results22021202240.020 Why?
ROC Curve1201736220.020 Why?
Neoplasm Invasiveness1201736310.020 Why?
Genomic Instability120137150.020 Why?
Acetylation1201110530.020 Why?
Hydroxamic Acids120114820.020 Why?
Time Factors22020402670.020 Why?
Alleles1201968920.020 Why?
Epigenesis, Genetic1202138260.020 Why?
Health Policy1202026980.020 Why?
Chemotherapy, Adjuvant1201635530.020 Why?
DNA-Binding Proteins1202496180.020 Why?
Gene Knockdown Techniques1201116080.020 Why?
Hypoxia-Inducible Factor 1, alpha Subunit120106230.020 Why?
Prevalence12023158680.020 Why?
Patient Education as Topic1201623370.020 Why?
Cluster Analysis1201327270.020 Why?
Carcinoma1201723400.020 Why?
Kaplan-Meier Estimate1201665410.020 Why?
Histone Deacetylase Inhibitors120117750.020 Why?
Bone Marrow1201629290.020 Why?
Proteomics1201939060.020 Why?
Positron-Emission Tomography1202266700.020 Why?
Promoter Regions, Genetic1201658000.010 Why?
Research1201219810.010 Why?
Boston1201793710.010 Why?
Transcription Factors12023121660.010 Why?
Kidney1201970630.010 Why?
Recurrence1201685010.010 Why?
Transcription, Genetic1201775990.010 Why?
Transfection1201157580.010 Why?
Transplantation, Heterologous1201123940.010 Why?
Parents1201635960.010 Why?
RNA, Small Interfering1201134360.010 Why?
Histones1201125930.010 Why?
Flow Cytometry1201158980.010 Why?
Antigens, CD1201140310.010 Why?
Magnetic Resonance Imaging22021368490.010 Why?
Tomography, X-Ray Computed12022207660.010 Why?
RNA, Messenger12013128010.010 Why?
Randomized Controlled Trials as Topic12014103770.010 Why?
New York119998840.010 Why?
Genotype12010130380.010 Why?
Carcinoma, Squamous Cell1201140690.010 Why?
Cross-Sectional Studies12016263730.010 Why?
Insurance Claim Review119997460.010 Why?
Case-Control Studies12011222920.010 Why?
Socioeconomic Factors1199978610.000 Why?
Logistic Models11999133230.000 Why?
Health Services Accessibility1199955110.000 Why?
Janeway's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (408)
Explore
_
Co-Authors (168)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.